SOLV vs VCYT: fair value comparison
Solventum Corporation and Veracyte, Inc. · Updated 2026-09-07
SOLV currently screens as overvalued while VCYT screens as fairly valued. Within Healthcare, VCYT currently sits closer to the top of our discount ranking. VCYT carries the stronger quality grade.
| SOLV | VCYT | |
|---|---|---|
| Verdict | Overvalued | Fairly valued |
| Last price | $91.69 | $44.85 |
| 12-month range | $64.35–$90.95 | $32.40–$59.85 |
| Sector rank | #87 of 113 Healthcare | #84 of 113 Healthcare |
| Quality grade | F | A |
| Leverage | High | Low |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | — | Overvalued |
| 52-week position | The top quarter | The lower-middle quarter |
Full single-stock breakdowns: SOLV fair value analysis · VCYT fair value analysis